首页 | 本学科首页   官方微博 | 高级检索  
检索        

6-羟基多巴在帕金森病发病机制中的作用
引用本文:马敬红,胡国华,董丽华,雄鹰,王为,宋月平,李淑娟.6-羟基多巴在帕金森病发病机制中的作用[J].吉林大学学报(医学版),2005,31(3):355-357.
作者姓名:马敬红  胡国华  董丽华  雄鹰  王为  宋月平  李淑娟
作者单位:首都医科大学宣武医院神经内科,北京,100053;吉林大学第二医院神经内科,吉林,长春,130041;吉林大学第二医院急救医学科,吉林,长春,130041;中国科学院大连化学物理研究所,辽宁,大连,116023
基金项目:国家高技术研究发展计划(863计划) , 国家计委科技攻关项目 , 国家自然科学基金
摘    要:目的:探讨神经毒素6-羟基多巴(6-OHDA)在帕金森病(PD)发病机制中的作用。 方法:采用立体定向术将神经毒素6-OHDA注入大鼠右侧纹状体内,制备经典的帕金森病动物模型。造模2个月后,检测其纹状体内还原型谷胱甘肽(GSH)和活性氧,并观察黑质的病理改变。结果:帕金森病模型组右侧纹状体内GSH含量[(36.85±8.64 μg•mg-1 prot)]明显下降,活性氧含量[(58.69±9.84)U•mg-1 prot]明显增高,与假手术组及正常对照组比较差异均有显著性(P<0.05)。光镜下可见帕金森病模型组右侧黑质致密带内多巴胺能神经元减少,与模型组左侧及对照组、假手术组黑质相比差异均有显著性(P<0.05)。 结论:6-OHDA可通过耗竭GSH及增加自由基的生成损害多巴胺能神经末梢,并逆行性损毁神经元胞体,导致黑质致密带多巴胺能神经元变性死亡。

关 键 词:羟基多巴类  帕金森病/病因学  谷胱甘肽  自由基
文章编号:1671-587X(2005)03-0355-03
收稿时间:2004-07-12
修稿时间:2004年7月12日

Role of 6-hydroxydopamine in pathogenesis of Parkinson's disease
MA Jing-hong,HU Guo-hua,DONG Li-hua,XIONG Ying,WANG Wei,SONG Yue-ping,LI Shu-juan.Role of 6-hydroxydopamine in pathogenesis of Parkinson's disease[J].Journal of Jilin University: Med Ed,2005,31(3):355-357.
Authors:MA Jing-hong  HU Guo-hua  DONG Li-hua  XIONG Ying  WANG Wei  SONG Yue-ping  LI Shu-juan
Institution:1. Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China;2. Department of Neurology, Second Hospital, Jilin University,Changchun 130041,China;3. Department of ICU, Second Hospital, Jilin University,Changchun 130041,China;4. Institute of Chemical Physics of Dalian, Chinese Academy of Sciences,Dalian 116023,China
Abstract:Objective To explore the role of 6-hydroxydopamine in the pathogenesis of Parkinson′s disease(PD). Methods The 6-hydroxydopamine(6-OHDA) was stereotaxically injected into the right striatum of rat to build the PD model. After two months, the levels of glutathione (GSH) and reactive oxygen in the striatum were measured, and the pathological changes in the substantia nigra (SN) were observed. Results The level of GSH of right side of striatum in model groups (36.85±8.64 μg·mg -1 prot) decreased significantly and the level of reactive oxygen (58.69±9.84 U·mg -1 prot)increased markedly. There were significant differences between the right and left striatum in animal model groups (P<0.05). Compared with the sham group and control group, there were also significant differences (P<0.05). The dopaminergic neuron number in the right SN in model group decreased significantly compared with the left SN, sham group, and control group (P<0.05). Conclusion 6-OHDA can increase the level of free radicals and decrease the level of GSH, thus leading to the oxidative lesions in SN and striatum and neuronal death.
Keywords:hydroxydopamines  Parkinson disease/etiology  glutathione  free radicals
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《吉林大学学报(医学版)》浏览原始摘要信息
点击此处可从《吉林大学学报(医学版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号